Lowell Blake & Associates’s Amgen AMGN Stock Holding History

Lowell Blake & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$346K	Hold	1,285	–	–	0.1%	48
2023 Q2	$285K	Sell	1,285 -1	-0.1%	-$232	0.08%	50
2023 Q1	$311K	Sell	1,286 -124	-9%	-$30.4K	0.1%	48
2022 Q4	$371K	Buy	1,410 +214	+18%	+$57.4K	0.12%	46
2022 Q3	$270K	Buy	1,196 +260	+28%	+$63K	0.11%	48
2022 Q2	$228K	Sell	936 -90	-9%	-$22.1K	0.09%	50
2022 Q1	$248K	Hold	1,026	–	–	0.09%	51
2021 Q4	$231K	Sell	1,026 -160	-13%	-$33.8K	0.09%	55
2021 Q3	$252K	Hold	1,186	–	–	0.12%	51
2021 Q2	$289K	Buy	+1,186	New	+$292K	0.13%	50
2020 Q4	–	Sell	-1,124	Closed	-$286K	–	44
2020 Q3	$286K	Hold	1,124	–	–	0.23%	43
2020 Q2	$265K	Sell	1,124 -575	-34%	-$131K	0.25%	44
2020 Q1	$344K	Hold	1,699	–	–	0.44%	38
2019 Q4	$410K	Buy	+1,699	New	+$375K	0.45%	39

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lowell Blake & Associates's AMGN Position: Q3 2023 in Review

Lowell Blake & Associates held its Amgen (AMGN) position steady in Q3 2023 at 1,285 shares worth $346K. The position accounts for 0.1% of the portfolio, ranked #48.

Lowell Blake & Associates first reported a position in AMGN in Q4 2019 and has held it in 14 quarters since. The position peaked at $410K in Q4 2019. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

Lowell Blake & Associates held 1,285 shares of Amgen worth $346K as of Q3 2023.
Lowell Blake & Associates left its Amgen share count unchanged in Q3 2023.
Amgen made up 0.1% of Lowell Blake & Associates's portfolio in Q3 2023, its #48 holding.
Lowell Blake & Associates first reported a position in Amgen in Q4 2019 and has held it in 14 quarters since.
Lowell Blake & Associates's Amgen position peaked at $410K in Q4 2019.
2,502 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Lowell Blake & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.